SG Micro Corp (03661) reported net profit attributable to shareholders of approximately RMB739 million for the first three quarters, up 115.28% year on year.
SG Micro Corp (03661) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB4.304 billion, up 53.69% year on year; net profit attributable to shareholders of the listed company of approximately RMB739 million, up 115.28% year on year; and basic earnings per share of RMB1.1524.
SG Micro Corp (03661) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB4.304 billion, up 53.69% year on year; net profit attributable to shareholders of the listed company of approximately RMB739 million, up 115.28% year on year; and basic earnings per share of RMB1.1524.
Related Articles
Victory Giant Technology (02476) plans to make additional investments of no more than US$800 million and US$700 million in its wholly-owned indirect subsidiaries Victory Giant Technology (Thailand) and Victory Giant Technology (Vietnam), respectively.
MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. reported a net profit attributable to shareholders of RMB449 million for the first three quarters, up 4.55% year on year.
KEYMED BIO-B (02162) intends to purchase shares under the 2022 Restricted Share Unit Plan.
Victory Giant Technology (02476) plans to make additional investments of no more than US$800 million and US$700 million in its wholly-owned indirect subsidiaries Victory Giant Technology (Thailand) and Victory Giant Technology (Vietnam), respectively.
MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. reported a net profit attributable to shareholders of RMB449 million for the first three quarters, up 4.55% year on year.
KEYMED BIO-B (02162) intends to purchase shares under the 2022 Restricted Share Unit Plan.
